We have located links that may give you full text access.
Dependence motives of young adult users of electronic nicotine delivery systems.
Addictive Behaviors 2019 Februrary 16
INTRODUCTION: Nicotine dependence contributes to changes in tobacco use among young adults. However, research examining salient dependence motives in young adult users of electronic nicotine delivery systems (ENDS) is limited. This study examined the association of dependence motives with ENDS use or lifetime quit attempt, and tests sex moderation in these relationships.
METHODS: Young adults (N = 304; age 18-24) self-identifying as regular ENDS users and self-reporting vaping within a week of data collection completed an online survey. They reported demographics, past 30-day vaping and smoking days and frequency, and lifetime quit attempt. Dependence motives were measured with the 14-item Wisconsin Inventory for Smoking Dependency Motives. Backward-stepwise models regressed ENDS use behaviors or lifetime quit attempt onto dependence motives, and separately onto the interactions between motives and sex.
RESULTS: Tolerance was positively associated with daily ENDS use frequency (b = 0.34, p < .001) past 30-day vaping days (b = 1.50, p < .001), and negatively associated with lifetime quit attempt (OR = 0.58, p = .005). Loss of control was negatively associated with daily ENDS use frequency (b = -0.24, p < .001) and past 30-day vaping days (b = -1.48, p < .001), and positively associated with lifetime quit attempt (OR = 1.56, p = .002). Craving was positively associated with lifetime quit attempt among males (OR = 1.83, p = .006) but not females (OR = 0.84, p = .51).
CONCLUSION: Tolerance and loss of control were uniquely associated with ENDS use behaviors across all analytic models, although effects for loss of control were counter-intuitive. Understanding the relationship between dependence motives and ENDS use behaviors or attempts to quit may provide targets for preventive interventions against increased or continued ENDS use.
METHODS: Young adults (N = 304; age 18-24) self-identifying as regular ENDS users and self-reporting vaping within a week of data collection completed an online survey. They reported demographics, past 30-day vaping and smoking days and frequency, and lifetime quit attempt. Dependence motives were measured with the 14-item Wisconsin Inventory for Smoking Dependency Motives. Backward-stepwise models regressed ENDS use behaviors or lifetime quit attempt onto dependence motives, and separately onto the interactions between motives and sex.
RESULTS: Tolerance was positively associated with daily ENDS use frequency (b = 0.34, p < .001) past 30-day vaping days (b = 1.50, p < .001), and negatively associated with lifetime quit attempt (OR = 0.58, p = .005). Loss of control was negatively associated with daily ENDS use frequency (b = -0.24, p < .001) and past 30-day vaping days (b = -1.48, p < .001), and positively associated with lifetime quit attempt (OR = 1.56, p = .002). Craving was positively associated with lifetime quit attempt among males (OR = 1.83, p = .006) but not females (OR = 0.84, p = .51).
CONCLUSION: Tolerance and loss of control were uniquely associated with ENDS use behaviors across all analytic models, although effects for loss of control were counter-intuitive. Understanding the relationship between dependence motives and ENDS use behaviors or attempts to quit may provide targets for preventive interventions against increased or continued ENDS use.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app